Biodexa Pharmaceuticals Future Growth
Future criteria checks 0/6
Se prevé que los ingresos deBiodexa Pharmaceuticals disminuyan a un ritmo anual de 66.4%.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Biotechs earnings growth | 20.9% |
Revenue growth rate | -66.4% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 08 Feb 2024 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | N/A | N/A | -21 | -21 | 1 |
12/31/2025 | N/A | N/A | -16 | -16 | 1 |
12/31/2024 | N/A | N/A | -11 | -11 | 1 |
12/31/2023 | 0 | N/A | N/A | -9 | 1 |
6/30/2023 | 1 | -8 | -7 | -7 | N/A |
3/31/2023 | 1 | -8 | -7 | -7 | N/A |
12/31/2022 | 1 | -8 | -7 | -7 | N/A |
9/30/2022 | 1 | -7 | -7 | -7 | N/A |
6/30/2022 | 1 | -5 | -7 | -6 | N/A |
3/31/2022 | 1 | -5 | -6 | -6 | N/A |
12/31/2021 | 1 | -5 | -6 | -6 | N/A |
9/30/2021 | 1 | -7 | -6 | -6 | N/A |
6/30/2021 | 1 | -8 | -6 | -5 | N/A |
3/31/2021 | 0 | -15 | -8 | -7 | N/A |
12/31/2020 | 0 | -22 | -10 | -9 | N/A |
6/30/2020 | 0 | -22 | -9 | -9 | N/A |
3/31/2020 | 1 | -16 | -8 | -8 | N/A |
12/31/2019 | 1 | -9 | -7 | -6 | N/A |
6/30/2019 | 2 | -9 | -10 | -10 | N/A |
3/31/2019 | 2 | -10 | -12 | -12 | N/A |
12/31/2018 | 2 | -10 | -14 | -13 | N/A |
6/30/2018 | 1 | -11 | -11 | -11 | N/A |
3/31/2018 | 1 | -11 | -13 | -12 | N/A |
12/31/2017 | 1 | -12 | -14 | -13 | N/A |
9/30/2017 | -3 | -1 | -16 | -14 | N/A |
6/30/2017 | 4 | -18 | -17 | -15 | N/A |
3/31/2017 | 6 | -19 | N/A | -14 | N/A |
12/31/2016 | 1 | -6 | N/A | -13 | N/A |
9/30/2016 | 5 | -17 | N/A | -14 | N/A |
6/30/2016 | 4 | -13 | N/A | -15 | N/A |
3/31/2016 | 3 | -12 | N/A | -14 | N/A |
12/31/2015 | 1 | -10 | N/A | -12 | N/A |
9/30/2015 | 1 | -10 | N/A | -11 | N/A |
6/30/2015 | 0 | -11 | N/A | -9 | N/A |
3/31/2015 | 0 | -10 | N/A | -7 | N/A |
12/31/2014 | 0 | -9 | N/A | -5 | N/A |
9/30/2014 | 0 | -7 | N/A | -5 | N/A |
6/30/2014 | 0 | -5 | N/A | -5 | N/A |
3/31/2014 | 0 | -4 | N/A | -5 | N/A |
12/31/2013 | 0 | -4 | N/A | -4 | N/A |
Analyst Future Growth Forecasts
Ingresos vs. tasa de ahorro: Datos insuficientes para determinar si el crecimiento previsto de los beneficios de BDRX es superior a la tasa de ahorro (2.2%).
Beneficios frente mercado: Datos insuficientes para determinar si se prevé que los beneficios de BDRX crezcan más deprisa que el mercado US
Beneficios de alto crecimiento: Datos insuficientes para determinar si se espera que los beneficios de BDRX crezcan significativamente en los próximos 3 años.
Ingresos vs. Mercado: BDRXSe prevé que los ingresos de la empresa disminuyan en los próximos 3 años (-66.4% al año).
Ingresos de alto crecimiento: BDRXSe prevé que los ingresos de la empresa disminuyan en los próximos 3 años (-66.4% al año).
Earnings per Share Growth Forecasts
Future Return on Equity
Futura rentabilidad financiera (ROE): Datos insuficientes para determinar si la Rentabilidad de los fondos propios de BDRX se prevé elevada dentro de 3 años.